<DOC>
	<DOCNO>NCT01923792</DOCNO>
	<brief_summary>House Dust Mites ( HDM ) arachnids infest bedding , carpet , upholstered furniture fabric . Like many allergen , exposure HDM allergen sensitise patient associate poor lung function , great medication requirement asthma symptom well chronic rhinosinusitis symptom . In contrast allergen , evidence HDMA lead development asthma , addition exacerbate pre-existing asthma HDM-sensitised patient . ToleroMune HDM currently develop treatment HDM allergy . The Purpose optional observational follow-on study evaluate continue efficacy TM-HDM HDM allergic subject base change TRSS TH002 baseline approximately two year completion baseline EEC visit TH002 follow challenge HDM allergen EEC .</brief_summary>
	<brief_title>ToleroMune House Dust Mite Follow Study</brief_title>
	<detailed_description>Subjects complete dose visit post treatment challenge ( PTC ) study TH002 invite attend Screening visit TH002a . Subjects attend 3 visit EEU successive day . Following last EEC visit follow-up visit perform 3-10 day later .</detailed_description>
	<mesh_term>Conjunctivitis</mesh_term>
	<criteria>previously randomise study TH002 , complete dose visit PTC `` Partly control '' `` uncontrolled '' asthma History anaphylaxis House Dust Mite allergen FEV1 &lt; 80 % predict . Symptoms clinically relevant illness Subjects tolerate allergen challenge EEC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>House Dust Mite Allergy</keyword>
	<keyword>Rhinoconjunctivitis</keyword>
	<keyword>Environmental Exposure Unit</keyword>
	<keyword>Immunotherapy</keyword>
	<keyword>ToleroMune HDM</keyword>
</DOC>